Matthew Brams's most recent trade in Cingulate Inc was a trade of 4,526 Common Stock done . Disclosure was reported to the exchange on March 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 4,526 | 9,182 | - | 0 | Common Stock | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Mar 2026 | 1,025 | 8,157 | - | 0 | Common Stock | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 06 Feb 2026 | 1,946 | 4,656 | - | 5.0 | 9,808 | Common Stock |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Feb 2026 | 1,556 | 1,556 | - | - | Warrant to Purchase Common Stock | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2025 | 52,500 | 52,500 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 17,630 | 17,630 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 2,748 | 2,748 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 63,324 | 63,324 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 16,676 | 16,676 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew N. Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 12,500 | 12,500 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Matthew Brams | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 4,492 | 4,492 | - | - | Stock Option (right to Buy) |